Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (221-230 of 470) with videos related to

Pageof 47
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 26, 2015
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancerYang Yang, Nandie Wu, Jie Shen, et al.
Investigational New Drugs|October 31, 2003
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphismAlbert Font, José Miguel Sánchez, Miquel Tarón, et al.
Cancers|August 14, 2019
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundAnastasios Gkountakos, Giulia Sartori, Italia Falcone, et al.
Journal of Translational Medicine|December 16, 2014
Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancerJie Shen, Jia Wei, Wenxian Guan, et al.
Journal of the National Cancer Institute|June 7, 2007
Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysisAndrea Ardizzoni, Luca Boni, Marcello Tiseo, et al.
Clinical Lung Cancer|March 20, 2019
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung CancerJordi Codony-Servat, Carles Codony-Servat, Andrés Felipe Cardona, et al.
Clinical Lung Cancer|March 18, 2009
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expressionRoberta Bartolucci, Jia Wei, Jose Javier Sanchez, et al.
Clinical Lung Cancer|July 6, 2011
Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patientsVega Iranzo, Rafael Sirera, Roy M Bremnes, et al.
NPJ Precision Oncology|July 16, 2021
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cellsMikkel G Terp, Kirstine Jacobsen, Miguel Angel Molina, et al.
Critical Reviews in Oncology/Hematology|December 10, 2023
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)Rafael Rosell, Jordi Codony-Servat, Jessica González, et al.
Pageof 47

Showing results (221-230 of 470) with videos related to

Sort By:
Pageof 47
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 26, 2015
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancerYang Yang, Nandie Wu, Jie Shen, et al.
Investigational New Drugs|October 31, 2003
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphismAlbert Font, José Miguel Sánchez, Miquel Tarón, et al.
Cancers|August 14, 2019
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundAnastasios Gkountakos, Giulia Sartori, Italia Falcone, et al.
Journal of Translational Medicine|December 16, 2014
Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancerJie Shen, Jia Wei, Wenxian Guan, et al.
Journal of the National Cancer Institute|June 7, 2007
Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysisAndrea Ardizzoni, Luca Boni, Marcello Tiseo, et al.
Clinical Lung Cancer|March 20, 2019
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung CancerJordi Codony-Servat, Carles Codony-Servat, Andrés Felipe Cardona, et al.
Clinical Lung Cancer|March 18, 2009
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expressionRoberta Bartolucci, Jia Wei, Jose Javier Sanchez, et al.
Clinical Lung Cancer|July 6, 2011
Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patientsVega Iranzo, Rafael Sirera, Roy M Bremnes, et al.
NPJ Precision Oncology|July 16, 2021
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cellsMikkel G Terp, Kirstine Jacobsen, Miguel Angel Molina, et al.
Critical Reviews in Oncology/Hematology|December 10, 2023
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)Rafael Rosell, Jordi Codony-Servat, Jessica González, et al.
Pageof 47